个人中心 - 老虎社区

kamy

IP属地：未知

帖子 · 166帖子 · 166
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- kamykamy
  ·2021-12-28
  Gg
  Novavax Falls Below Support: What Does This Mean For The Vaccine Stock?<blockquote>Novavax跌破支撑位：这对疫苗股意味着什么？</blockquote>
  Novavax, Inc. shares are trading lower Monday, slightly falling below a pattern the stock has been t
  Novavax Falls Below Support: What Does This Mean For The Vaccine Stock?<blockquote>Novavax跌破支撑位：这对疫苗股意味着什么？</blockquote>
  2,636 评论
  4
  分享
  举报
- kamykamy
  ·2021-12-28
  Gg
  Why Novavax Stock Is Sinking Today<blockquote>为什么Novavax股票今天下跌</blockquote>
  What happened Shares of Novavax(NASDAQ:NVAX)were sinking 9.6% as of 11:47 a.m. ET on Monday. The com
  Why Novavax Stock Is Sinking Today<blockquote>为什么Novavax股票今天下跌</blockquote>
  2,995 评论
  2
  分享
  举报
- kamykamy
  ·2021-12-28
  Good
  非常抱歉，此主贴已删除
  2,886 评论
  3
  分享
  举报
- kamykamy
  ·2021-12-28
  Gg
  非常抱歉，此主贴已删除
  2,585 评论
  3
  分享
  举报
- kamykamy
  ·2021-12-26
  Gg
  Why Twilio Stock Is Still Slumping<blockquote>为什么Twilio股价仍在暴跌</blockquote>
  Twilio(NYSE:TWLO) is having a tough time pulling back from the tech wreck of 2021. The cloud communi
  Why Twilio Stock Is Still Slumping<blockquote>为什么Twilio股价仍在暴跌</blockquote>
  3,593 1
  3
  分享
  举报
- kamykamy
  ·2021-12-26
  Gg
  非常抱歉，此主贴已删除
  3,902 评论
  6
  分享
  举报
- kamykamy
  ·2021-12-26
  Good
  非常抱歉，此主贴已删除
  4,507 1
  6
  分享
  举报
- kamykamy
  ·2021-12-23
  Gg
  非常抱歉，此主贴已删除
  3,809 评论
  点赞
  分享
  举报
- kamykamy
  ·2021-12-21
  Gg
  非常抱歉，此主贴已删除
  2,809 评论
  点赞
  分享
  举报
- kamykamy
  ·2021-12-21
  Gg
  非常抱歉，此主贴已删除
  2,301 评论
  2
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3559267712174688","uuid":"3559267712174688","gmtCreate":1596173842012,"gmtModify":1706620602012,"name":"kamy","pinyin":"kamy","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/88a23e0929fe2bdeac54d613c0b7197d","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":42,"headSize":585,"tweetSize":166,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.19%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.05.04","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.18%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":696620078,"gmtCreate":1640685398417,"gmtModify":1640685654346,"author":{"id":"3559267712174688","authorId":"3559267712174688","name":"kamy","avatar":"https://static.tigerbbs.com/88a23e0929fe2bdeac54d613c0b7197d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3559267712174688","idStr":"3559267712174688"},"themes":[],"htmlText":"Gg","listText":"Gg","text":"Gg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696620078","repostId":"1180788153","repostType":4,"repost":{"id":"1180788153","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1640685275,"share":"https://www.laohu8.com/m/news/1180788153?lang=zh_CN&edition=full","pubTime":"2021-12-28 17:54","market":"us","language":"en","title":"Novavax Falls Below Support: What Does This Mean For The Vaccine Stock?<blockquote>Novavax跌破支撑位：这对疫苗股意味着什么？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1180788153","media":"Benzinga","summary":"Novavax, Inc. shares are trading lower Monday, slightly falling below a pattern the stock has been t","content":"<p><b>Novavax, Inc.</b>&nbsp;shares are trading lower Monday, slightly falling below a pattern the stock has been&nbsp;trading in. On Thursday, the company said it expanded a license agreement for its NVX-CoV2373 recombinant nanoparticle protein-based COVID-19 vaccine with SK Bioscience Co.</p><p><blockquote><b>诺瓦瓦克斯公司。</b>周一股价走低，略低于该股一直以来的交易模式。周四，该公司表示，它扩大了与SK Bioscience Co.的NVX-CoV2373重组纳米颗粒蛋白COVID-19疫苗的许可协议。</blockquote></p><p> Novavax was down 10.97% at $157.80&nbsp;at market close Monday.</p><p><blockquote>截至周一收盘，Novavax下跌10.97%，至157.80美元。</blockquote></p><p> <b>Novavax Daily Chart Analysis</b></p><p><blockquote><b>Novavax日线图分析</b></blockquote></p><p> <ul>  <li>Shares look to have fallen slightly below the support in what traders call a pennant pattern. If this support line begins to hold as resistance, the stock could be ready for a further bearish push.</li>  <li>The stock trades below both the 50-day moving average (green) and the 200-day moving average (blue). This indicates the sentiment is bearish&nbsp;and each of these moving averages may hold as an area of resistance in the future.</li>  <li>The Relative Strength Index (RSI) has been falling the past few days and now sits at 42. This shows an increase in the number of sellers in the stock and shows sellers have overtaken control of the stock once again.</li> </ul> <img src=\"https://static.tigerbbs.com/dfccb243932c8070edf22f4cbf757df0\" tg-width=\"2400\" tg-height=\"1233\" width=\"100%\" height=\"auto\"></p><p><blockquote><ul><li>股价似乎已略低于交易员看涨期权三角旗形态的支撑位。如果这条支撑线开始作为阻力，该股可能会进一步看跌。</li><li>该股交易价格低于50日移动平均线（绿色）和200日移动平均线（蓝色）。这表明市场情绪是看跌的，这些移动平均线中的每一条都可能在未来成为阻力区域。</li><li>相对强弱指数(RSI)过去几天一直在下跌，目前为42。这表明该股卖家数量有所增加，并表明卖家再次控制了该股。</li></ul></blockquote></p><p> <b>What’s Next For Novavax?</b></p><p><blockquote><b>Novavax的下一步是什么？</b></blockquote></p><p> Traders should take caution as the stock fell out of the pennant pattern. The stock will either recover and continue trading within the pattern or it will hold the pattern support line as an area of resistance. Bulls want to see the stock recover and continue to trade in the pattern&nbsp;and eventually are looking for a break above resistance. Bears are looking to see the stock fall below the support line and begin to hold it as an area of resistance. This may cause a further bearish push in the future.</p><p><blockquote>随着该股跌出三角旗形态，交易者应保持谨慎。该股要么恢复并继续在该模式内交易，要么将该模式支撑线作为阻力区域。多头希望看到该股复苏并继续以该模式交易，并最终寻求突破阻力位。空头希望看到该股跌破支撑线，并开始将其作为阻力区域持有。这可能会导致未来进一步看跌。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Falls Below Support: What Does This Mean For The Vaccine Stock?<blockquote>Novavax跌破支撑位：这对疫苗股意味着什么？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Falls Below Support: What Does This Mean For The Vaccine Stock?<blockquote>Novavax跌破支撑位：这对疫苗股意味着什么？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-12-28 17:54</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><b>Novavax, Inc.</b>&nbsp;shares are trading lower Monday, slightly falling below a pattern the stock has been&nbsp;trading in. On Thursday, the company said it expanded a license agreement for its NVX-CoV2373 recombinant nanoparticle protein-based COVID-19 vaccine with SK Bioscience Co.</p><p><blockquote><b>诺瓦瓦克斯公司。</b>周一股价走低，略低于该股一直以来的交易模式。周四，该公司表示，它扩大了与SK Bioscience Co.的NVX-CoV2373重组纳米颗粒蛋白COVID-19疫苗的许可协议。</blockquote></p><p> Novavax was down 10.97% at $157.80&nbsp;at market close Monday.</p><p><blockquote>截至周一收盘，Novavax下跌10.97%，至157.80美元。</blockquote></p><p> <b>Novavax Daily Chart Analysis</b></p><p><blockquote><b>Novavax日线图分析</b></blockquote></p><p> <ul>  <li>Shares look to have fallen slightly below the support in what traders call a pennant pattern. If this support line begins to hold as resistance, the stock could be ready for a further bearish push.</li>  <li>The stock trades below both the 50-day moving average (green) and the 200-day moving average (blue). This indicates the sentiment is bearish&nbsp;and each of these moving averages may hold as an area of resistance in the future.</li>  <li>The Relative Strength Index (RSI) has been falling the past few days and now sits at 42. This shows an increase in the number of sellers in the stock and shows sellers have overtaken control of the stock once again.</li> </ul> <img src=\"https://static.tigerbbs.com/dfccb243932c8070edf22f4cbf757df0\" tg-width=\"2400\" tg-height=\"1233\" width=\"100%\" height=\"auto\"></p><p><blockquote><ul><li>股价似乎已略低于交易员看涨期权三角旗形态的支撑位。如果这条支撑线开始作为阻力，该股可能会进一步看跌。</li><li>该股交易价格低于50日移动平均线（绿色）和200日移动平均线（蓝色）。这表明市场情绪是看跌的，这些移动平均线中的每一条都可能在未来成为阻力区域。</li><li>相对强弱指数(RSI)过去几天一直在下跌，目前为42。这表明该股卖家数量有所增加，并表明卖家再次控制了该股。</li></ul></blockquote></p><p> <b>What’s Next For Novavax?</b></p><p><blockquote><b>Novavax的下一步是什么？</b></blockquote></p><p> Traders should take caution as the stock fell out of the pennant pattern. The stock will either recover and continue trading within the pattern or it will hold the pattern support line as an area of resistance. Bulls want to see the stock recover and continue to trade in the pattern&nbsp;and eventually are looking for a break above resistance. Bears are looking to see the stock fall below the support line and begin to hold it as an area of resistance. This may cause a further bearish push in the future.</p><p><blockquote>随着该股跌出三角旗形态，交易者应保持谨慎。该股要么恢复并继续在该模式内交易，要么将该模式支撑线作为阻力区域。多头希望看到该股复苏并继续以该模式交易，并最终寻求突破阻力位。空头希望看到该股跌破支撑线，并开始将其作为阻力区域持有。这可能会导致未来进一步看跌。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180788153","content_text":"Novavax, Inc. shares are trading lower Monday, slightly falling below a pattern the stock has been trading in. On Thursday, the company said it expanded a license agreement for its NVX-CoV2373 recombinant nanoparticle protein-based COVID-19 vaccine with SK Bioscience Co.\nNovavax was down 10.97% at $157.80 at market close Monday.\nNovavax Daily Chart Analysis\n\nShares look to have fallen slightly below the support in what traders call a pennant pattern. If this support line begins to hold as resistance, the stock could be ready for a further bearish push.\nThe stock trades below both the 50-day moving average (green) and the 200-day moving average (blue). This indicates the sentiment is bearish and each of these moving averages may hold as an area of resistance in the future.\nThe Relative Strength Index (RSI) has been falling the past few days and now sits at 42. This shows an increase in the number of sellers in the stock and shows sellers have overtaken control of the stock once again.\n\n\nWhat’s Next For Novavax?\nTraders should take caution as the stock fell out of the pennant pattern. The stock will either recover and continue trading within the pattern or it will hold the pattern support line as an area of resistance. Bulls want to see the stock recover and continue to trade in the pattern and eventually are looking for a break above resistance. Bears are looking to see the stock fall below the support line and begin to hold it as an area of resistance. This may cause a further bearish push in the future.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":2636,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696889265,"gmtCreate":1640661988460,"gmtModify":1640661988956,"author":{"id":"3559267712174688","authorId":"3559267712174688","name":"kamy","avatar":"https://static.tigerbbs.com/88a23e0929fe2bdeac54d613c0b7197d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3559267712174688","idStr":"3559267712174688"},"themes":[],"htmlText":"Gg","listText":"Gg","text":"Gg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696889265","repostId":"1187889461","repostType":4,"repost":{"id":"1187889461","kind":"news","pubTimestamp":1640657510,"share":"https://www.laohu8.com/m/news/1187889461?lang=zh_CN&edition=full","pubTime":"2021-12-28 10:11","market":"us","language":"en","title":"Why Novavax Stock Is Sinking Today<blockquote>为什么Novavax股票今天下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1187889461","media":"Motley Fool","summary":"What happened\nShares of Novavax(NASDAQ:NVAX)were sinking 9.6% as of 11:47 a.m. ET on Monday. The com","content":"<p>What happened</p><p><blockquote>发生了什么</blockquote></p><p> Shares of&nbsp;<b>Novavax</b>(NASDAQ:NVAX)were sinking 9.6% as of 11:47 a.m. ET on Monday. The company didn't announce any new developments. So what's behind the big decline?</p><p><blockquote>本公司之股份<b>Novavax</b>截至美国东部时间周一上午11:47，（纳斯达克：NVAX）股价下跌9.6%。该公司没有宣布任何新的进展。那么大跌的背后是什么呢？</blockquote></p><p> Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p><p><blockquote>其他疫苗股的跌幅也没有那么大。有些甚至涨了一点。这排除了对奥密克戎变种的担忧下降是Novavax股价下跌的主要因素的可能性。</blockquote></p><p> Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p><p><blockquote>相反，投资者可能对Novavax计划向美国申请其COVID-19疫苗NVX-CoV2373紧急使用授权(EUA)越来越焦虑。一些投资者还可能担心Novavax向美国食品和药物管理局(FDA)提交的文件的质量，即使它的提交没有再次出现延迟。</blockquote></p><p> CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p><p><blockquote>首席执行官斯坦利·埃尔克接受雅虎采访！上周四的金融直播可能并没有让投资者放心。当被问及何时完成FDA备案时，Erck回答说：“可能是下周，但我坚持认为我们将在今年年底前完成这项工作。”</blockquote></p><p> So what</p><p><blockquote>那又怎样</blockquote></p><p> Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p><p><blockquote>只要Novavax在新年尽快完成提交，NVX-CoV2373在美国的申请再次延迟对该公司来说不会是灾难性的。然而，管理层的信誉肯定会再次受到重大打击。</blockquote></p><p> But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p><p><blockquote>但目前推测Novavax本周不会完成美国EUA备案还为时过早。担心该公司FDA包装的质量也是没有用的。Novavax最近获得了NVX-CoV2373的欧盟授权。这表明疫苗制造商能够成功满足监管机构的生产质量障碍。</blockquote></p><p> Now what</p><p><blockquote>现在怎么办</blockquote></p><p> Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p><p><blockquote>投资者不喜欢等待，但这正是他们目前对Novavax必须做的事情。该公司现在可以随时完成EUA备案。它还可能在等待监管决定的其他国家获得新的授权。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Is Sinking Today<blockquote>为什么Novavax股票今天下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Is Sinking Today<blockquote>为什么Novavax股票今天下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-12-28 10:11</span>\n</p>\n</h4>\n</header>\n<article>\n<p>What happened</p><p><blockquote>发生了什么</blockquote></p><p> Shares of&nbsp;<b>Novavax</b>(NASDAQ:NVAX)were sinking 9.6% as of 11:47 a.m. ET on Monday. The company didn't announce any new developments. So what's behind the big decline?</p><p><blockquote>本公司之股份<b>Novavax</b>截至美国东部时间周一上午11:47，（纳斯达克：NVAX）股价下跌9.6%。该公司没有宣布任何新的进展。那么大跌的背后是什么呢？</blockquote></p><p> Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p><p><blockquote>其他疫苗股的跌幅也没有那么大。有些甚至涨了一点。这排除了对奥密克戎变种的担忧下降是Novavax股价下跌的主要因素的可能性。</blockquote></p><p> Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p><p><blockquote>相反，投资者可能对Novavax计划向美国申请其COVID-19疫苗NVX-CoV2373紧急使用授权(EUA)越来越焦虑。一些投资者还可能担心Novavax向美国食品和药物管理局(FDA)提交的文件的质量，即使它的提交没有再次出现延迟。</blockquote></p><p> CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p><p><blockquote>首席执行官斯坦利·埃尔克接受雅虎采访！上周四的金融直播可能并没有让投资者放心。当被问及何时完成FDA备案时，Erck回答说：“可能是下周，但我坚持认为我们将在今年年底前完成这项工作。”</blockquote></p><p> So what</p><p><blockquote>那又怎样</blockquote></p><p> Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p><p><blockquote>只要Novavax在新年尽快完成提交，NVX-CoV2373在美国的申请再次延迟对该公司来说不会是灾难性的。然而，管理层的信誉肯定会再次受到重大打击。</blockquote></p><p> But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p><p><blockquote>但目前推测Novavax本周不会完成美国EUA备案还为时过早。担心该公司FDA包装的质量也是没有用的。Novavax最近获得了NVX-CoV2373的欧盟授权。这表明疫苗制造商能够成功满足监管机构的生产质量障碍。</blockquote></p><p> Now what</p><p><blockquote>现在怎么办</blockquote></p><p> Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p><p><blockquote>投资者不喜欢等待，但这正是他们目前对Novavax必须做的事情。该公司现在可以随时完成EUA备案。它还可能在等待监管决定的其他国家获得新的授权。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/12/27/why-novavax-stock-is-sinking-today/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2021/12/27/why-novavax-stock-is-sinking-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187889461","content_text":"What happened\nShares of Novavax(NASDAQ:NVAX)were sinking 9.6% as of 11:47 a.m. ET on Monday. The company didn't announce any new developments. So what's behind the big decline?\nOther vaccine stocks aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.\nInstead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.\nCEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"\nSo what\nYet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.\nBut it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.\nNow what\nInvestors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":2995,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696889814,"gmtCreate":1640661969464,"gmtModify":1640661969890,"author":{"id":"3559267712174688","authorId":"3559267712174688","name":"kamy","avatar":"https://static.tigerbbs.com/88a23e0929fe2bdeac54d613c0b7197d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3559267712174688","idStr":"3559267712174688"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696889814","repostId":"1198327529","repostType":4,"isVote":1,"tweetType":1,"viewCount":2886,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696889997,"gmtCreate":1640661895766,"gmtModify":1640661896228,"author":{"id":"3559267712174688","authorId":"3559267712174688","name":"kamy","avatar":"https://static.tigerbbs.com/88a23e0929fe2bdeac54d613c0b7197d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3559267712174688","idStr":"3559267712174688"},"themes":[],"htmlText":"Gg","listText":"Gg","text":"Gg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696889997","repostId":"1127544468","repostType":4,"isVote":1,"tweetType":1,"viewCount":2585,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698464558,"gmtCreate":1640499056292,"gmtModify":1640499222268,"author":{"id":"3559267712174688","authorId":"3559267712174688","name":"kamy","avatar":"https://static.tigerbbs.com/88a23e0929fe2bdeac54d613c0b7197d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3559267712174688","idStr":"3559267712174688"},"themes":[],"htmlText":"Gg","listText":"Gg","text":"Gg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698464558","repostId":"1100809123","repostType":4,"repost":{"id":"1100809123","kind":"news","pubTimestamp":1640484960,"share":"https://www.laohu8.com/m/news/1100809123?lang=zh_CN&edition=full","pubTime":"2021-12-26 10:16","market":"us","language":"en","title":"Why Twilio Stock Is Still Slumping<blockquote>为什么Twilio股价仍在暴跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1100809123","media":"InvestorPlace","summary":"Twilio(NYSE:TWLO) is having a tough time pulling back from the tech wreck of 2021. The cloud communi","content":"<p><div> Twilio(NYSE:TWLO) is having a tough time pulling back from the tech wreck of 2021. The cloud communications platform as a service posted strong quarterly results. Active customer accounts grew. ...</p><p><blockquote><div>Twilio（纽约证券交易所股票代码：TWLO）正在艰难地从2021年的科技灾难中恢复过来。云通信平台即服务公布了强劲的季度业绩。活跃客户账户增长。...</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/12/why-twilio-stock-is-still-slumping/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/12/why-twilio-stock-is-still-slumping/\">网页连接</a></blockquote></p><p></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Twilio Stock Is Still Slumping<blockquote>为什么Twilio股价仍在暴跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Twilio Stock Is Still Slumping<blockquote>为什么Twilio股价仍在暴跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">InvestorPlace</strong><span class=\"h-time small\">2021-12-26 10:16</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Twilio(NYSE:TWLO) is having a tough time pulling back from the tech wreck of 2021. The cloud communications platform as a service posted strong quarterly results. Active customer accounts grew. ...</p><p><blockquote><div>Twilio（纽约证券交易所股票代码：TWLO）正在艰难地从2021年的科技灾难中恢复过来。云通信平台即服务公布了强劲的季度业绩。活跃客户账户增长。...</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/12/why-twilio-stock-is-still-slumping/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/12/why-twilio-stock-is-still-slumping/\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://investorplace.com/2021/12/why-twilio-stock-is-still-slumping/\">InvestorPlace</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWLO":"Twilio Inc"},"source_url":"https://investorplace.com/2021/12/why-twilio-stock-is-still-slumping/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100809123","content_text":"Twilio(NYSE:TWLO) is having a tough time pulling back from the tech wreck of 2021. The cloud communications platform as a service posted strong quarterly results. Active customer accounts grew. Investors of TWLO Stock, however, are in for a big surprise.\nThe company initiated fourth-quarter guidance, which included non-GAAP losses. Since November, investors of  TWLO stock faced downward selling pressure after investors shunned high valuation stocks. Despite the volatility, why is Twilio a compelling worthwhile long-term investment?\nTWLO Stock Under Pressure\nTwilio announced third-quarter revenue of $740.2 million. Losses almost doubled from $112.3 million last year to $232.3 million. Still, on a non-GAAP EPS basis, it earned a penny, or $8.2 million. Even after losing 10% of its value in the month and 40% from 52-week highs, the market capitalization is almost $50 billion. Investors are nervous that the small profit will not rise in the coming quarters.\nFortunately, Twilio’s quarter revenue is growing consistently in the low 60% range. Revenue growthof 46% in Q2/2020(slide 5) is a low point. Given the increasing uncertainties from Covid-19, markets are worried that Twilio’s business growth may lose momentum. Omicron is confusing investors. They are not sure that business customers will face a slowdown. That would hurt Twilio’s strong active customer account growth.\nModest Slowdown\nIn Q3, Twilio’s dollar-based net expansion rate fell slightly, from 137% in Q3/2020 to 131%. After it acquired Zipwhip and Segment, completed in July 2021for $850 million, its communications platform should attract growth.\nSimon Khalaf, SVP and general manager of the Twilio Communications Platform, said that Zipwhip would leverage Twilio’s messaging expertise across its channels. The unit will suit customers of all sizes since they will get a suite of messaging offerings.\nLast year,Twilio acquired Segment. It wrapped up the$3.2 billion purchase quickly. Segment adds developer tools to the platform. Twilio benefits from having a set of communication APIs (application programming interfaces). Segment focuses on interacting with customers and managing that data.\nOpportunity For TWLO Stock\nTwilio will sustain organic growth of at least 30% or more in the next three years. It has broad exposure geographically. Segment demonstrated strong quarterly performance. This gives management the confidence that its business momentum will continue.\nThe company has a vision of becoming a leading customer engagement platform. It will get there by following its product roadmap in the next few years. It has plenty of cash on hand ($1.497 billion as of Sept. 30, 2021) for mergers in acquisitions. After a few big purchases in the last year, Twilio will take its time to acquire other firms to fuel growth.\nSince company targets still trade at premiums, Twilio will be selective about its opportunities. It has a solid technology stack. It will pursue any outside solutions that add to the platform at the right price. For now, the firm will capture more of its addressable market by providing digital transformation solutions for customers.\nIn 2022, Twilio will turn its attention to developing its customer engagement platform. This includes growing customer awareness forTwilio Engage. This is an omnichannel growth platform. Customers may build and optimize marketing campaigns using its tools, analytics, and data integrations.\nRisks\nApple’s advertising identifier advertisers, called IDFA, may potentially limit a customer’s view of data. Still, Twilio believes it will provide the antidote to IDFA tag changes. For example, its customers will have first-party signals from customers as opposed to third-party data.\nAt a macro level, the company will help its customers grow its relationships with their customers. Business customers have not only Twilio’s messaging products but up-sold products like Segment. In 2022, its general availability rollout will lift revenue and profit margins.\nDowntrend Chart and Fair Value\nIn the chart below, Twilio stock is still working off bearish selling volume. It faces resistance at the 50-day and 200-day simple moving average.On Wall Street, 18 out of 19 analysts rate TWLO shares as a buy. The price target ranges from $350 to $550,according to Tipranks. The analyst support for Twilio’s prospects could lead to buyers returning to the stock early next year.\nYour Takeaway\nOver-priced software stocks are in a bear market. Twilio is a marketing and communications platform that posted its first quarterly revenue. After adding new features and rolling out the improved solution in 2022, growth could expand. Investors should keep this stock on the radar.\nInvestors cannot time when the selling pressure will end. Look for the widely-held value software stocks to rebound first. If the Nasdaq accompanies that uptrend, TWLO stock recovery will soon follow.","news_type":1,"symbols_score_info":{"TWLO":0.9}},"isVote":1,"tweetType":1,"viewCount":3593,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698464286,"gmtCreate":1640498990267,"gmtModify":1640499221820,"author":{"id":"3559267712174688","authorId":"3559267712174688","name":"kamy","avatar":"https://static.tigerbbs.com/88a23e0929fe2bdeac54d613c0b7197d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3559267712174688","idStr":"3559267712174688"},"themes":[],"htmlText":"Gg","listText":"Gg","text":"Gg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698464286","repostId":"2193781141","repostType":4,"isVote":1,"tweetType":1,"viewCount":3902,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698464346,"gmtCreate":1640498940638,"gmtModify":1640498941107,"author":{"id":"3559267712174688","authorId":"3559267712174688","name":"kamy","avatar":"https://static.tigerbbs.com/88a23e0929fe2bdeac54d613c0b7197d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3559267712174688","idStr":"3559267712174688"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698464346","repostId":"2193178197","repostType":4,"isVote":1,"tweetType":1,"viewCount":4507,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691678702,"gmtCreate":1640189099415,"gmtModify":1640189257857,"author":{"id":"3559267712174688","authorId":"3559267712174688","name":"kamy","avatar":"https://static.tigerbbs.com/88a23e0929fe2bdeac54d613c0b7197d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3559267712174688","idStr":"3559267712174688"},"themes":[],"htmlText":"Gg","listText":"Gg","text":"Gg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691678702","repostId":"2193019234","repostType":4,"isVote":1,"tweetType":1,"viewCount":3809,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693527868,"gmtCreate":1640051939461,"gmtModify":1640051939888,"author":{"id":"3559267712174688","authorId":"3559267712174688","name":"kamy","avatar":"https://static.tigerbbs.com/88a23e0929fe2bdeac54d613c0b7197d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3559267712174688","idStr":"3559267712174688"},"themes":[],"htmlText":"Gg","listText":"Gg","text":"Gg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693527868","repostId":"2193131366","repostType":4,"isVote":1,"tweetType":1,"viewCount":2809,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693524174,"gmtCreate":1640051859758,"gmtModify":1640051860220,"author":{"id":"3559267712174688","authorId":"3559267712174688","name":"kamy","avatar":"https://static.tigerbbs.com/88a23e0929fe2bdeac54d613c0b7197d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3559267712174688","idStr":"3559267712174688"},"themes":[],"htmlText":"Gg","listText":"Gg","text":"Gg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693524174","repostId":"2193761136","repostType":4,"isVote":1,"tweetType":1,"viewCount":2301,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}